SCIESCOPUSQ2
Journal of Immunotherapy and Precision Oncology
Innovative Healthcare Institute, United States
Journal of Immunotherapy and Precision Oncology is an academic journal published by Innovative Healthcare Institute (United States). Identifiers: ISSN 2666-2345, eISSN 2590-017X. Indexed in SCIE, SCOPUS. Metrics: JIF 3.2, CiteScore 3.5, SJR 1.285, SNIP 0.53. tlooto lists 250 papers from this journal.
CiteScore
3.50
Scopus citation metric
SJR
1.285
SCImago rank
SNIP
0.53
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2666-2345
- eISSN
- 2590-017X
- Abbreviation
- J IMMUNOTHER PRECIS
- Publisher
- Innovative Healthcare Institute
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
1306 Cancer Research2403 Immunology2723 Immunology and Allergy2730 Oncology
Papers in this journal
Recent papers
- Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies
2026
- Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond
2026
- SMARCA4-Directed Treatment in Oncology Clinical Trials: A Review
2026
- The Double-Edged Role of Social Media in Modern Healthcare: Awareness, Impact, and Misinformation
2026 · 1 citations
- ESR1-Guided Endocrine Switching in HR-Positive Metastatic Breast Cancer: From Detection to Risk-Adapted Decision in SERENA-6
2026
Most cited papers
- Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
2022 · 94 citations
- B7-H3 Inhibitors in Oncology Clinical Trials: A Review
2023 · 60 citations
- The impact of immune checkpoint inhibitor-related adverse events and their immunosuppressive treatment on patients' outcomes
2018 · 47 citations
- Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) Inhibitors.
2021 · 40 citations
- Extracellular signal-regulated kinase (ERK) inhibitors in oncology clinical trials
2019 · 33 citations